221 related articles for article (PubMed ID: 29449434)
41. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.
Lennard L; Richards S; Cartwright CS; Mitchell C; Lilleyman JS; Vora A;
Clin Pharmacol Ther; 2006 Oct; 80(4):375-83. PubMed ID: 17015055
[TBL] [Abstract][Full Text] [Related]
42. A lack of DNA mismatch repair on an athymic murine background predisposes to hematologic malignancy.
Campbell MR; Nation PN; Andrew SE
Cancer Res; 2005 Apr; 65(7):2626-35. PubMed ID: 15805259
[TBL] [Abstract][Full Text] [Related]
43. Compound heterozygosity for MSH6 mutations in a pediatric lymphoma patient.
Peters A; Born H; Ettinger R; Levonian P; Jedele KB
J Pediatr Hematol Oncol; 2009 Feb; 31(2):113-5. PubMed ID: 19194194
[TBL] [Abstract][Full Text] [Related]
44. Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia.
Evans WE; Horner M; Chu YQ; Kalwinsky D; Roberts WM
J Pediatr; 1991 Dec; 119(6):985-9. PubMed ID: 1960624
[TBL] [Abstract][Full Text] [Related]
45. Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells.
Diouf B; Cheng Q; Krynetskaia NF; Yang W; Cheok M; Pei D; Fan Y; Cheng C; Krynetskiy EY; Geng H; Chen S; Thierfelder WE; Mullighan CG; Downing JR; Hsieh P; Pui CH; Relling MV; Evans WE
Nat Med; 2011 Sep; 17(10):1298-303. PubMed ID: 21946537
[TBL] [Abstract][Full Text] [Related]
46. Feasibility of monitoring peripheral blood to detect emerging clones in children with acute lymphoblastic leukemia
Saliba J; Evensen NA; Meyer JA; Newman D; Nersting J; Narang S; Ma X; Schmiegelow K; Carroll WL
Pediatr Blood Cancer; 2020 Jul; 67(7):e28306. PubMed ID: 32391957
[TBL] [Abstract][Full Text] [Related]
47. CRISPR/Cas9-Mediated Induction of Relapse-Specific
Nguyen TTT; Tanaka Y; Sanada M; Hosaka M; Tamai M; Kagami K; Komatsu C; Somazu S; Harama D; Kasai S; Watanabe A; Akahane K; Goi K; Inukai T
Mol Pharmacol; 2023 Apr; 103(4):199-210. PubMed ID: 36669880
[TBL] [Abstract][Full Text] [Related]
48. Mutator phenotype in Msh2-deficient murine embryonic fibroblasts.
Reitmair AH; Risley R; Bristow RG; Wilson T; Ganesh A; Jang A; Peacock J; Benchimol S; Hill RP; Mak TW; Fishel R; Meuth M
Cancer Res; 1997 Sep; 57(17):3765-71. PubMed ID: 9288785
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of rs62527607 [GT] single nucleotide polymorphism located in BAALC gene in children with acute leukemia using mismatch PCR-RFLP.
Nadimi M; Rahgozar S; Moafi A; Tavassoli M; Mesrian Tanha H
Cancer Genet; 2016; 209(7-8):348-53. PubMed ID: 27372260
[TBL] [Abstract][Full Text] [Related]
50. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
[TBL] [Abstract][Full Text] [Related]
51. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP
PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540
[TBL] [Abstract][Full Text] [Related]
52. Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
Schmiegelow K; Forestier E; Kristinsson J; Söderhäll S; Vettenranta K; Weinshilboum R; Wesenberg F;
Leukemia; 2009 Mar; 23(3):557-64. PubMed ID: 18987654
[TBL] [Abstract][Full Text] [Related]
53. Impaired transport as a mechanism of resistance to thiopurines in human T-lymphoblastic leukemia cells.
Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1039-44. PubMed ID: 17065061
[TBL] [Abstract][Full Text] [Related]
54. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
[TBL] [Abstract][Full Text] [Related]
55. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
56. DHFR and MSH3 co-amplification in childhood acute lymphoblastic leukaemia, in vitro and in vivo.
Matheson EC; Hogarth LA; Case MC; Irving JA; Hall AG
Carcinogenesis; 2007 Jun; 28(6):1341-6. PubMed ID: 17148505
[TBL] [Abstract][Full Text] [Related]
57. Role of TPMT and ITPA variants in mercaptopurine disposition.
Gerbek T; Ebbesen M; Nersting J; Frandsen TL; Appell ML; Schmiegelow K
Cancer Chemother Pharmacol; 2018 Mar; 81(3):579-586. PubMed ID: 29387964
[TBL] [Abstract][Full Text] [Related]
58. Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia.
Pieters R; Hongo T; Loonen AH; Huismans DR; Broxterman HJ; Hählen K; Veerman AJ
Br J Cancer; 1992 May; 65(5):691-7. PubMed ID: 1350207
[TBL] [Abstract][Full Text] [Related]
59. The MitoNEET Ligand NL-1 Mediates Antileukemic Activity in Drug-Resistant B-Cell Acute Lymphoblastic Leukemia.
Geldenhuys WJ; Nair RR; Piktel D; Martin KH; Gibson LF
J Pharmacol Exp Ther; 2019 Jul; 370(1):25-34. PubMed ID: 31010844
[TBL] [Abstract][Full Text] [Related]
60. The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells.
Fink D; Nebel S; Norris PS; Aebi S; Kim HK; Haas M; Howell SB
Br J Cancer; 1998 Mar; 77(5):703-8. PubMed ID: 9514047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
